The differences observed at baseline in the frequencies of certain subsets based on CD39 and CD73 expression did not correspond to significant variations in the plasmatic ATP concentration between RA patients and Cs (27.51 (32.56) and 35.47 (113.73) nM, respectively). This evidence concerns the gene ENTPD1 and rheumatoid arthritis.